Treatment of heart failure after myocardial infarction with bone marrow-derived mesenchymal stem cells
Heart failure (HF) after myocardial infarction (MI) represents a worldwide public health issue with gradually increasing incidence. HF may eventually affect all organs and tissues and is associated with significant morbidity and mortality. Current therapeutic methods to treat HF stay at only delayin...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Health/LWW
2016-01-01
|
| Series: | Cardiology Plus |
| Subjects: | |
| Online Access: | http://www.cardiologyplus.org/article.asp?issn=2470-7511;year=2016;volume=1;issue=1;spage=15;epage=21;aulast=Yu |